High Solubilization and Controlled Release of Paclitaxel Using Thermosponge Nanoparticles for Effective Cancer Therapy
Cancer, which is a leading cause of death, contributes significantly to reducing life expectancy worldwide. Even though paclitaxel (PTX) is known as one of the main anticancer drugs, it has several limitations, including low solubility in aqueous solutions, a limited dosage range, an insufficient re...
Main Authors: | Jin Sil Lee, Hyeryeon Oh, Daekyung Sung, Jin Hyung Lee, Won Il Choi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/8/1150 |
Similar Items
-
Solubilization Methods for Paclitaxel and Docetaxel: An Overview
by: Fariba Pourkarim, et al.
Published: (2022-04-01) -
Investigation of drug release from paclitaxel loaded polylactic acid nanofibers
by: Amir Doustgani
Published: (2016-07-01) -
Hydrotropic Hydrogels Prepared from Polyglycerol Dendrimers: Enhanced Solubilization and Release of Paclitaxel
by: Tooru Ooya, et al.
Published: (2022-09-01) -
Pure paclitaxel nanoparticles: preparation, characterization, and antitumor effect for human liver cancer SMMC-7721 cells
by: Wu C, et al.
Published: (2018-10-01) -
Polyhydroxyalkanoate Decelerates the Release of Paclitaxel from Poly(lactic-co-glycolic acid) Nanoparticles
by: Si Yeong Lee, et al.
Published: (2022-08-01)